GnRH agonist trigger after GnRH antagonist cotreatment for prevention of OHSS in patients with polycystic ovarian syndrome (PCOS).

被引：0
|
作者：
Engmann, L.
Tuccillo, C.
Schmidt, D.
Nulsen, J.
Maier, D.
Benadiva, C.
机构：
[1] Univ Connecticut, Ctr Hlth, Farmington, CT USA
[2] Univ Connecticut, Ctr Adv Reprod Serv, Farmington, CT USA
来源：
FERTILITY AND STERILITY | 2006年 / 86卷
关键词：
D O I：
10.1016/j.fertnstert.2006.07.1268
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S460 / S461
页数：2
相关论文
共 50 条
  • [1] A case of ovarian hyperstimulation syndrome using GnRH agonist to trigger oocyte maturation after cotreatment with GnRH antagonist
    Kovachev, E.
    [J]. 13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 329 - 332
  • [2] Prevention of ovarian hyperstimulation syndrome (OHSS) with the use of gonadotropin releasing hormone (GnRH) agonist to trigger final oocyte maturation after cotreatment with GnRH antagonist in patients with polycystic ovarian syndrome (PCOS) or previous high response undergoing IVF treatment - A prospective randomized clinical trial.
    Engmann, L
    Diluigi, A
    Schmidt, D
    Nulsen, J
    Maier, D
    Benadiva, C
    [J]. FERTILITY AND STERILITY, 2005, 84 : S96 - S96
  • [3] Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation
    Kol, Shahar
    Dor, Jehoshua
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (01) : 59 - 60
  • [4] Severe OHSS can be prevented in GnRH antagonist protocol using GnRH agonist to trigger ovulation.
    Chun, E
    [J]. FERTILITY AND STERILITY, 2005, 84 : S301 - S301
  • [5] Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients
    Ensieh Shahrokh Tehraninejad
    Roya Nasiri
    Batool Rashidi
    Fedieh Haghollahi
    Marzieh Ataie
    [J]. Archives of Gynecology and Obstetrics, 2010, 282 : 319 - 325
  • [6] Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients
    Tehraninejad, Ensieh Shahrokh
    Nasiri, Roya
    Rashidi, Batool
    Haghollahi, Fedieh
    Ataie, Marzieh
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 282 (03) : 319 - 325
  • [7] A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
    Yanagihara, Yasuho
    Tanaka, Atsushi
    Nagayoshi, Motoi
    Tanaka, Izumi
    Shinohara, Rina
    Fukushima, Fumihisa
    Tanaka, Akihiro
    Ohno, Motoharu
    Yamaguchi, Takashi
    Itakura, Atsuo
    [J]. REPRODUCTIVE MEDICINE AND BIOLOGY, 2022, 21 (01)
  • [8] The use of GnRH agonist to trigger final stages of oocyte maturation in patients with polycystic ovarian syndrome (PCOS) and high responders during IVF treatment
    Engmann, L
    Hartnett, J
    Siano, L
    Schmidt, D
    Nulsen, J
    Maier, D
    Benadiva, C
    [J]. FERTILITY AND STERILITY, 2005, 83 : S26 - S27
  • [9] Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization
    Fauser, BC
    de Jong, D
    Olivennes, F
    Wramsby, H
    Tay, C
    Itskovitz-Eldor, J
    van Hooren, HG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02): : 709 - 715
  • [10] Strategy to prevent the failure of GnRH agonist (GnRH-a) to trigger final oocyte maturation in patients with high risk of OHSS stimulated with antagonist protocol
    Visnova, H.
    Huttelova, R.
    Budka, S.
    Bahnikova, M.
    [J]. HUMAN REPRODUCTION, 2014, 29 : 344 - 344
12345